Malaysia Intranasal Drug And Vaccine Delivery Market Size & Outlook
Malaysia intranasal drug and vaccine delivery market, 2018-2030 (US$M)
Related Markets
Malaysia intranasal drug and vaccine delivery market highlights
- The Malaysia intranasal drug and vaccine delivery market generated a revenue of USD 1,129.0 million in 2023 and is expected to reach USD 1,745.1 million by 2030.
- The Malaysia market is expected to grow at a CAGR of 6.4% from 2024 to 2030.
- In terms of segment, liquid delivery device was the largest revenue generating product in 2023.
- Pressurized Metered Dose Inhaler is the most lucrative product segment registering the fastest growth during the forecast period.
Intranasal drug and vaccine delivery market data book summary
| Market revenue in 2023 | USD 1,129.0 million |
| Market revenue in 2030 | USD 1,745.1 million |
| Growth rate | 6.4% (CAGR from 2023 to 2030) |
| Largest segment | Liquid delivery device |
| Fastest growing segment | Pressurized Metered Dose Inhaler |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Powder delivery device, Liquid Delivery Device, Pressurized Metered Dose Inhaler |
| Key market players worldwide | GSK PLC ADR, Teva Pharmaceutical Industries Ltd, AptarGroup Inc, UCB SA, Teleflex Inc, 3M Co, OptiNose Inc, Bespak, Intersect ENT |
Other key industry trends
- In terms of revenue, Malaysia accounted for 1.7% of the global intranasal drug and vaccine delivery market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China intranasal drug and vaccine delivery market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 5,992.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Intranasal Drug And Vaccine Delivery Market Scope
Intranasal Drug And Vaccine Delivery Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Malaysia intranasal drug and vaccine delivery market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intranasal drug and vaccine delivery market will help companies and investors design strategic landscapes.
Liquid delivery device was the largest segment with a revenue share of 40.81% in 2023. Horizon Databook has segmented the Malaysia intranasal drug and vaccine delivery market based on powder delivery device, liquid delivery device, pressurized metered dose inhaler covering the revenue growth of each sub-segment from 2018 to 2030.
Malaysia has a dual healthcare system in which both the public and private players are present. The public healthcare system is understaffed but there is constant increase in investments by the Malaysian government. The private sector medical facilities are generally used by the upper-class affluent citizens.
Healthcare coverage is provided by both public and private players. Malaysia imports medical consumables from countries like Japan, Germany, America, and South Korea.
Reasons to subscribe to Malaysia intranasal drug and vaccine delivery market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Malaysia intranasal drug and vaccine delivery market databook
-
Our clientele includes a mix of intranasal drug and vaccine delivery market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Malaysia intranasal drug and vaccine delivery market , including forecasts for subscribers. This country databook contains high-level insights into Malaysia intranasal drug and vaccine delivery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Malaysia intranasal drug and vaccine delivery market size, by product, 2018-2030 (US$M)
Malaysia Intranasal Drug And Vaccine Delivery Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
